Anthem Biosciences Limited (BOM:544449)
950.95
+13.20 (1.41%)
At close: Nov 20, 2026
Anthem Biosciences Market Cap
Anthem Biosciences has a market cap or net worth of 535.63 billion as of November 20, 2026. Its market cap has increased by 48.36% in one year.
Market Cap
535.63B
Enterprise Value
528.99B
Revenue
20.50B
Global Rank
n/a
Country Rank
n/a
PE Ratio
87.89
ChartMarket Cap Chart
Since July 21, 2025, Anthem Biosciences's market cap has increased from 410.17B to 535.63B, an increase of 30.59%. That is a compound annual growth rate of 22.14%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 535.63B | 46.39% |
| Dec 31, 2025 | 365.89B | -10.80% |
| Jul 21, 2025 | 410.17B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biocon | 593.35B |
| Anthem Biosciences | 534.47B |
| OneSource Specialty Pharma | 184.62B |
| Concord Biotech | 114.76B |
| Blue Jet Healthcare | 97.24B |
| Supriya Lifescience | 50.06B |
| Zota Health Care | 44.82B |
| Panacea Biotec | 20.64B |